首页资讯雅培推出全新Protality品牌高蛋白营养奶昔

雅培推出全新Protality品牌高蛋白营养奶昔

来源：泰然健康网时间：2024年12月21日 04:23

Abbott (ABT), Wednesday announced the launch of its new Protality brand, a high-protein nutrition shake.According to Abbott, Protality is the first product in this line to support the growing number of adults interested in pursuing weight loss while maintaining muscle mass and good nutrition.'It's critical for adults on weight loss regimens to prioritize good nutrition to ensure they get enough micronutrients and protein to preserve muscle mass while consuming limited calories,' said Hakim Bouzamondo, division vice president of Nutrition Research and Development at Abbott.

雅培（Abbott）周三宣布推出其新的Protality品牌，一种高蛋白营养奶昔。据雅培介绍，Protality是这一系列的第一款产品，它支持越来越多的成年人在保持肌肉质量和良好营养的同时追求减肥雅培（Abbott）营养研究与开发部副总裁哈基姆·布扎蒙多（HakimBouzamondo）说，成年人减肥方案的关键是优先考虑良好的营养，以确保他们获得足够的微量营养素和蛋白质来保持肌肉质量，同时消耗有限的卡路里。

'We've studied muscle health and nutrition for decades at Abbott. We understand that a weight loss journey can be challenging, which is why we're launching the PROTALITY brand to give adults nutritional products with an excellent source of high-quality protein and nutrients to support muscle health.'.

“几十年来，我们一直在雅培研究肌肉健康和营养。我们理解减肥之旅可能具有挑战性，这就是为什么我们推出PROTALITY品牌，为成年人提供优质蛋白质和营养素的优质营养产品，以支持肌肉健康。”。

To preserve muscle mass during weight loss, research shows adults may need at least 50 percent more protein than the Recommended Dietary Allowance (RDA). High protein consumption can also support weight loss maintenance. For comments and feedback contact: editorial@rttnews.comBusiness News

为了在减肥过程中保持肌肉质量，研究表明，成年人可能需要比推荐的饮食量（RDA）至少多50%的蛋白质。高蛋白质消耗也可以支持减肥维持。如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻

Biotech Stocks Facing FDA Decision In November 2023

2023年11月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In October 2023

2023年10月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision in August 2023

2023年8月美国食品和药物管理局（FDA）决定生物技术股

网址: 雅培推出全新Protality品牌高蛋白营养奶昔 https://www.trfsz.com/newsview689378.html